Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Further characterization of a pathological isoantithrombin with no affinity for heparin (antithrombin III Roma).

De Stefano V, Leone G, Ferrelli R, Di Donfrancesco A, De Martini D, Bizzi B.

Thromb Res. 1987 Oct 1;48(1):23-30.

PMID:
3424283
2.
3.
4.

AT III Barcelona: a familial quantitative-qualitative AT III deficiency.

Grau E, Fontcuberta J, Félez J, de Diego I, Soto R, Rutllant ML.

Thromb Haemost. 1988 Feb 25;59(1):13-7.

PMID:
3363529
6.

Quantitative and qualitative congenital deficiency of antithrombin III: a new molecular variant called ATIII-Barcelona 2.

Fontcuberta J, Grau E, Rubio N, Félez J, Rutllant ML.

Thromb Res. 1988 Jul 1;51(1):75-81.

PMID:
3413737
7.

A new familial variant of antithrombin III: 'antithrombin III Paris'.

Wolf M, Boyer C, Lavergne JM, Larrieu MJ.

Br J Haematol. 1982 Jun;51(2):285-95.

PMID:
7082587
8.

Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.

Jørgensen M, Petersen LC, Thorsen S.

J Lab Clin Med. 1984 Aug;104(2):245-56.

PMID:
6747440
9.

Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.

De Stefano V, Leone G, Mastrangelo S, Lane DA, Girolami A, de Moerloose P, Sas G, Abildgaard U, Blajchman M, Rodeghiero F, et al.

Blood Coagul Fibrinolysis. 1994 Feb;5(1):7-15.

PMID:
8180341
10.

Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect.

De Stefano V, Leone G, De Carolis MP, Ferrelli R, De Carolis S, Pagano L, Tortorolo G, Bizzi B.

Thromb Haemost. 1987 Jun 3;57(3):329-31.

PMID:
3660333
11.

Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.

Tripodi A, Krachmalnicoff A, Mannucci PM.

Thromb Haemost. 1986 Dec 15;56(3):349-52.

PMID:
3563966
12.

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.

Lane DA, Flynn A, Ireland H, Erdjument H, Samson D, Howarth D, Thompson E.

Br J Haematol. 1987 Apr;65(4):451-6.

PMID:
3580302
13.

Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.

Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.

Thromb Haemost. 1989 Feb 28;61(1):20-4.

PMID:
2749590
14.

Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.

Okajima K, Abe H, Wagatsuma M, Okabe H, Takatsuki K.

Am J Hematol. 1995 Jan;48(1):12-8.

PMID:
7832187
15.

Antithrombin III Alger: a new homozygous AT III variant.

Fischer AM, Cornu P, Sternberg C, Mériane F, Dautzenberg MD, Chafa O, Beguin S, Desnos M.

Thromb Haemost. 1986 Apr 30;55(2):218-21.

PMID:
3715788
16.

Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.

Barrowcliffe TW.

Thromb Haemost. 1980 Feb 29;42(5):1434-45.

PMID:
7368150
17.

An abnormal antithrombin III (AT III) with low heparin affinity: AT III Clichy.

Aiach M, François D, Priollet P, Capron L, Roncato M, Alhenc-Gelas M, Fiessinger JN.

Br J Haematol. 1987 Aug;66(4):515-22.

PMID:
3663508
18.
19.

Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

Wolf M, Boyer C, Tripodi A, Meyer D, Larrieu MJ, Mannucci PM.

Blood. 1985 Feb;65(2):496-500.

20.
Items per page

Supplemental Content

Support Center